Table 2.
Specific miRNAs with reported roles in periodontal inflammation
| miRNA | Differential regulation in ‘diseased’ vs. ‘healthy’ gingival tissues |
Reported function | Comment |
|---|---|---|---|
| Let-7i | Upregulated | Targets TLR4 | |
| miR-16 | Upregulated | Activated by p53, facilitates cell cycle arrest and apoptosis |
|
| miR-29a | Upregulated | Downregulates IL-23 by targeting IL12p40 and p19; inhibits both intrinsic and extrinsic apoptosis; hypoxamir, induces angiogenesis in hypoxia; mediates osteoblast differentiation by targeting Wnt signaling inhibitors |
|
| miR-30e | Downregulated | Inhibits NK cell cytotoxicity | |
| miR-31 | Downregulated | Targets a negative regulator of NF-kB; mediates osteoclastogenesis and represses osteogenesis by targeting Osterix |
|
| miR-125-3p | Upregulated | Activates p53, pro-apoptotic | |
| miR-141 | Downregulated | Targets MAP4K4 (a direct inducer of MAP kinase signaling) and SDF- 1/CXCL12 (mediator of leukocyte migration) |
|
| miR-146a | Upregulated | NF-kB dependent miRNA that targets TLR4, IRAK1/TRAF4; increases DC survival by reducing their cytokine production; regulates B cell development, ‘brake’ on autoimmunity; activated by periodontitis-associated TF Bob1 |
Critical for steering TLR sensitivity |
| miR-148a | Upregulated | Impairs innate response and antigen presentation of DCs; targets anti- apoptotic Bcl2; mediates osteoclastogenesis |
|
| miR-155 | Upregulated | miRNA that targets NF-kB signaling; activated by NF-kB, fos/jun, NOD2 signaling, mediates type 1 interferon response to infection; activates PI3K/Akt pathway; induces activation of NK cells; critical for DC maturation and function; essential for Th17 response and T cell development; inhibits DNA damage-induced apoptosis; hypoxamir that triggers cell cycle arrest, induces autophagy and targets HIF-1α in hypoxia (pro- survival); induced by adiponectin stimulation |
Critical for steering TLR sensitivity, directly affects expression level of other miRNAs; miR-155 targeting improves chronic inflammatory diseases |
| miR-185 | Upregulated | Enhances DNA damage-induced apoptosis |
|
| miR-200a | Downregulated | Negatively regulates IL-12 signaling in NK cells |
|
| miR-200c | Downregulated | Targets TLR4; targets pro-apoptotic Noxa and anti-apoptotic FAP-1; inhibits endothelial cell differentiation and angiogenesis; induces osteoclastogenesis |
|
| miR-203 | Downregulated | Targets VEGFA, inhibiting angiogenesis | |
| miR-210 | Downregulated | Impairs immune-suppressive functions of Tregs by targeting FOXP3; hypoxamir, controls host responses in hypoxia by induction of autophagy and targeting of HIF-1α (pro-survival) |
|
| miR-451 | Upregulated | Suppresses neutrophil chemotaxis via p38 MAPK; reduces cytokine secretion in DCs |
Dicer-independent miRNA |
| miR-486 | Upregulated | Disrupts NF-kB negative feedback loops, leading to stronger NF-kB activation |
|
| miR-497 | Upregulated | Facilitates intrinsic apoptosis | |
| miR-650 | Upregulated | Regulates B cell proliferation by targeting CDK1 |